{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:05:44Z","timestamp":1771862744207,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12928-020-00689-9","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T13:06:10Z","timestamp":1593781570000},"page":"281-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early vascular response of ultra-thin bioresorbable polymer sirolimus-eluting stents assessed by optical frequency domain imaging: the EVALUATION study"],"prefix":"10.1007","volume":"36","clinical-trial-number":[{"clinical-trial-number":"umin000033406","registry":"10.18810\/umin-japan"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-0530","authenticated-orcid":false,"given":"Takashi","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Senda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuhachi","family":"Otagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Saigusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Motoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uichi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"689_CR1","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"MC Morice","year":"2002","unstructured":"Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773\u201380.","journal-title":"N Engl J Med"},{"key":"689_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O\u2019Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315\u201323.","journal-title":"N Engl J Med"},{"key":"689_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jacc.2013.05.022","volume":"62","author":"T Palmerini","year":"2013","unstructured":"Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabat\u00e9 M, Valgimigli M, et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013;62:496\u2013504.","journal-title":"J Am Coll Cardiol"},{"key":"689_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"6","author":"PW Serruys","year":"2013","unstructured":"Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, et al. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. JACC Cardiovasc Interv. 2013;6:777\u201389.","journal-title":"JACC Cardiovasc Interv."},{"key":"689_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamacardio.2019.1776","volume":"4","author":"RA Buiten","year":"2019","unstructured":"Buiten RA, Ploumen EH, Zocca P, Doggen CJM, van der Heijden LC, Kok MM, et al. Outcomes in patients treated with thin-strut, very thin-strut, or ultrathin-strut drug-eluting stents in small coronary vessels: a prespecified analysis of the randomized BIO-RESORT trial. JAMA Cardiol. 2019;4:659\u201369.","journal-title":"JAMA Cardiol."},{"key":"689_CR6","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1016\/j.jacc.2018.09.019","volume":"72","author":"DE Kandzari","year":"2018","unstructured":"Kandzari DE, Koolen JJ, Doros G, Massaro JJ, Garcia-Garcia HM, Bennett J, et al. Bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents. J Am Coll Cardiol. 2018;72:3287\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"689_CR7","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","volume":"123","author":"K Kolandaivelu","year":"2011","unstructured":"Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation. 2011;123:1400\u20139.","journal-title":"Circulation"},{"key":"689_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28228","author":"M Iannaccone","year":"2019","unstructured":"Iannaccone M, Gatti P, Barbero U, Bassignana A, Gallo D, de Benedictis M, et al. Impact of strut thickness and number of crown and connectors on clinical outcomes on patients treated with second-generation drug eluting stent. Catheter Cardiovasc Interv. 2019. https:\/\/doi.org\/10.1002\/ccd.28228.","journal-title":"Catheter Cardiovasc Interv."},{"key":"689_CR9","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.118.034456","volume":"138","author":"S Bangalore","year":"2018","unstructured":"Bangalore S, Toklu B, Patel N, Feit F, Stone GW. Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease. Circulation. 2018;138:2216\u201326.","journal-title":"Circulation"},{"key":"689_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","volume":"394","author":"JF Iglesias","year":"2019","unstructured":"Iglesias JF, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, et al. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet. 2019;394:1243\u201353.","journal-title":"Lancet"},{"key":"689_CR11","doi-asserted-by":"publisher","first-page":"e003255","DOI":"10.1161\/JAHA.116.003255","volume":"5","author":"R Zbinden","year":"2016","unstructured":"Zbinden R, Piccolo R, Heg D, Roffi M, Kurz DJ, Muller O, et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial. J Am Heart Assoc. 2016;5:e003255.","journal-title":"J Am Heart Assoc."},{"key":"689_CR12","first-page":"40","volume":"20","author":"T Sato","year":"2018","unstructured":"Sato T, Taya Y, Suzuki N, Yuasa S, Kishi S, Koshikawa T, et al. The comparison of early healing 1-month after PCI among CoCr-everolimus-eluting stent (EES), biodegradable polymer (BP)-EES and BP-sirolimus-eluting stent: insights from OFDI and coronary angioscopy. Int J Cardiol Heart Vasc. 2018;20:40\u20135.","journal-title":"Int J Cardiol Heart Vasc."},{"key":"689_CR13","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.cjca.2019.07.633","volume":"35","author":"T Shinke","year":"2019","unstructured":"Shinke T, Itoh T, Ishida M, Otake H, Terashita D, Fusazaki T, et al. Early and mid-term vascular response to optical coherence tomography-guided everolimus-eluting stent implantation in stable coronary artery disease. Can J Cardiol. 2019;35:1513\u201322.","journal-title":"Can J Cardiol"},{"key":"689_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ahj.2012.01.007","volume":"163","author":"H Kitabata","year":"2012","unstructured":"Kitabata H, Kubo T, Komukai K, Ishibashi K, Tanimoto T, Ino Y, et al. Effect of strut thickness on neointimal atherosclerotic change over an extended follow-up period (>\/=\u20094\u00a0years) after bare-metal stent implantation: intracoronary optical coherence tomography examination. Am Heart J. 2012;163:608\u201316.","journal-title":"Am Heart J"},{"key":"689_CR15","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/jama.2019.8145","volume":"321","author":"H Watanabe","year":"2019","unstructured":"Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. JAMA. 2019;321:2414\u201327.","journal-title":"JAMA"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-020-00689-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-020-00689-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-020-00689-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:52:45Z","timestamp":1628614365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-020-00689-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1007\/s12928-020-00689-9","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by each of the hospitals\u2019 ethics committees and was performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}